Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma

Hepatology. 2019 Dec;70(6):2216-2217. doi: 10.1002/hep.30813. Epub 2019 Aug 7.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin
  • Carcinoma, Hepatocellular*
  • Humans
  • Liver Neoplasms*
  • Risk Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Aspirin